Entourage Health Corp (TSE:ENTG) has released an update.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Entourage Health Corp has reported robust financial results for Q3 2024, with total revenue of $13.6 million and a significant 70% improvement in EBITDA for the quarter. The company also achieved a notable 32% reduction in SG&A expenses, highlighting its progress towards profitability in the stabilizing cannabis industry.
For further insights into TSE:ENTG stock, check out TipRanks’ Stock Analysis page.